Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Kidney Neoplasms, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07061769 2025-07-11

Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device

Phase NA Enrolling by invitation

50 enrolled

Chemotherapy Induced Peripheral Neuropathy

NCT07053904 2025-07-08

Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors

Phase 1 Enrolling by invitation

54 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT07046832 2025-07-02

Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy

Phase NA Enrolling by invitation

104 enrolled

GastrointestinalGenitourinary

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Neoplasms

NCT06992687 2025-05-28

A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors

Phase 1/2 Enrolling by invitation

30 enrolled

Other solid neoplasm

Solid Tumors

NCT06940648 2025-05-06

VIABLE

Phase NA Enrolling by invitation

30 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT06925685 2025-04-13

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product

Enrolling by invitation

50 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT04915495 2025-03-21

The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia

Phase NA Enrolling by invitation

400 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT04145375 2025-03-19

Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol

Phase 1/2 Enrolling by invitation

40 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

Development and Application of Patient-Derived Models of Cancer

Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies

PERSIST

ziMyG+

LTFS

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

NOECHO

ROSY-D

SAFE-3CV

RESTORE LB

A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product

ADAPT Jr +

A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment

GYNORYLAQ™

Posterior Cervical Fixation Study

KANNON-2

A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.

A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

RegisterNET

A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients

Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors

Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma

Clinical Trial to Treat Stage IV Cancer Patients

HTK_002

XS-03-II201

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

BrainMets AI

K-ACCELERATE

DESCENT-1

Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device

Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors

Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy

A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors

VIABLE

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product

The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia

Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol